Lesley C. is a highly experienced leader in the field of bioprocessing and cellular therapies, currently serving as Senior Director at bluebird bio since January 2016, overseeing critical programs related to gene-modified hematopoietic stem and progenitor cell therapies. With a background that includes roles such as Senior Director of Process Sciences and Innovations and Associate Director of Cellular Process Development, Lesley has consistently driven the advancement of manufacturing processes and lentiviral vector platforms. Additional contributions to the scientific community include membership on the Board of Directors and Advisory Board at WEST - Women in the Enterprise of Science and Technology. Lesley's academic credentials include a Ph.D. in Bioengineering from the National University of Singapore and a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto.